TECNIS ODYSSEY TORIC II IOL DRT225 (REF DRT2250090)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TEC ODYSSEY TOR II SMPCY 09.0D CYL2.25 · Class 3 · Implant
All models of TECNIS ODYSSEY TORIC II IOL (106)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474811720), received between Sep 11, 2026 and Sep 11, 2026 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Blurred Vision1
- Dry Eye(s)1
- Halo1
- Retinal Detachment1
- Vitreous Floaters1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 11, 2026Adverse Event Without Identified Device or Use Problem
It was reported that following implantation of a preloaded multifocal Toric intraocular lens (IOL) in the patient's right eye, the patient experienced halos at night and difficulty with both distance and near vision. The patient reported that halos remained present; however, her primary concern was poor near and distance vision. The patient indicated that she relied primarily on her left eye, which retained the natural lens and utilized a contact lens, for functional vision.The patient reported discussing her symptoms with the implanting physician and was advised to allow additional time for adaptation because the lens was reported to be well positioned and centered. The patient was prescribed glasses; however, no new prescription was provided, and the patient stated that her near vision was worse while wearing the glasses. The patient reported using Restasis® eye drops for dry eye management.The patient stated that she remained able to perform activities of daily living by relying on her left eye and utilizing multiple pairs of glasses and sunglasses. The patient reported that no medications outside the standard of care were prescribed and that she planned to obtain a second opini
Patient problems: Blurred Vision; Dry Eye(s); Halo; Retinal Detachment; Vitreous Floaters
MAUDE report 50735061 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page